Midlife Dementia Delay Trajectory Explorer

Cohort Risk Archetypes Age 50 Baseline

Midlife Interventions (Ages 45–60)

Systolic BP Control (<130 mmHg)

+4.8 yrs delay

Mitigates midlife cerebral microvascular damage, white matter hyperintensities & blood-brain barrier leakage.

Active Protection

Metabolic & HbA1c Regulation

+4.2 yrs delay

Prevents insulin resistance-induced neuroinflammation and advanced glycation end-product accumulation.

Active Protection

Aerobic Physical Activity (150m/wk)

+4.1 yrs delay

Up-regulates brain-derived neurotrophic factor (BDNF), enhances hippocampal perfusion and neurogenesis.

Active Protection

High Cognitive-Social Reserve

+2.2 yrs delay

Builds redundant synaptic connectivity and compensatory pathways tolerating neuropathology.

Inactive Factor

Projected Onset Delay +13.1 yrs Max cumulative shift

Median Onset Age 87.3 yrs vs 74.2 baseline

Hazard Reduction @ 80 58.4% Incidence RR: 0.416

Dominant Factor BP Control 4.8 yrs (36.6% share)

Dementia-Free Survival & Incidence Hazard Curve Follow-up from age 50 to 95 across 12,000-adult longitudinal cohort

Baseline Cohort (74.2y median)

Projected Trajectory (+13.1y)

Decade-by-Decade Clinical Incidence Rates Cases per 1,000 Person-Years (n=12,000)

Decade Milestone	Age Span	Baseline Cohort Rate	Intervention Trajectory	Absolute Risk Delta	Relative Protection

Epidemiological Insight: Modifying the three core midlife risk factors (blood pressure, glucose regulation, and aerobic activity) during your 50s yields an estimated 13.1-year median onset delay. Vascular integrity and metabolic preservation in midlife protect against early cerebral small vessel disease before irreversible amyloid and tau cascades propagate.